Evidence map›Paper›PMID 42568483›Full record

ArticleFrontiers in oncology2026

A rare case report on esophageal squamous cell carcinoma metastatic to the colon.

Lixia Hu, Yanyan Zha, Chengfa Li, Mengqin Huang, Qianqian Yuan, Yan Wu, Wei Cheng

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lixia HuDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Yanyan ZhaDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Chengfa LiDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Mengqin HuangDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Qianqian YuanDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Yan WuDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Wei ChengDepartment of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal squamous cell carcinoma(ESCC) carries a poor prognosis with low survival rates, frequently due to advanced disease at diagnosis. Colonic metastasis from ESCC is exceptionally rare. This report describes the case of a 68-year-old male with locally advanced ESCC who developed metachronous colonic metastasis during follow-up after initial definitive chemoradiotherapy combined with immunotherapy. Pathological examination of a colonic biopsy confirmed metastatic squamous cell carcinoma with an immunohistochemical profile consistent with esophageal origin. The patient subsequently received systemic chemotherapy followed by combined immunotherapy, achieving a partial response on imaging evaluation. This case not only underscores the rarity of colonic metastasis in ESCC but also highlights the critical importance of maintaining vigilance for this possibility within multidisciplinary care and long-term follow-up.

Indexed as

case reportcolonic metastasisesophageal squamous cell carcinomaimmunotherapyrare metastasis

Identifiers

PMID42568483
PMCPMC13447186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.